Qiagen N.V. Share Price & Technical Analysis

QGEN · $35.17 (+0.80%)

Healthcare / Diagnostics & Research

AI Score 41 · Weak

$35.17

+0.80%

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technolo

Price chart

Seasonality

May has 5 positive and 0 negative years (last 5 years shown)

1% return in May, 3% avg return in past 3 year May month.

-17% return in 2026, -2% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
2619%-5%-18%-14%1%-17%
250%-13%4%6%6%7%3%-7%-5%4%3%-6%2%
24-2%-2%0%-2%3%-5%9%2%2%-7%1%2%2%
23-1%-6%0%-2%1%-1%3%-3%-11%-7%10%6%-12%
22-10%0%-2%-8%1%3%6%-9%-8%4%12%0%-11%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 41/100

Weak · Downtrend · Neutral

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$6.93B

P/E ratio

17.15

52W high

$57.82

52W low

$32.53

Volume

9,83,556

Beta

0.64

Related stocks in Healthcare

Frequently asked questions

What is Qiagen N.V. share price today?
Qiagen N.V. (QGEN) last traded around $35.17 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does QGEN have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for QGEN. Download the app for real-time alerts.
How can I analyze Qiagen N.V. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro